Literature DB >> 23806030

Synthesis of 2'-deoxy-9-deaza nucleosides using Heck methodology.

Kartik Temburnikar1, Kelin Brace, Katherine L Seley-Radtke.   

Abstract

During the synthesis of a series of 2'-deoxy-9-deaza nucleosides using Heck methodology, the necessity for a pyrrole protecting group was discovered. The results of this brief study revealed that the benzyloxymethyl (BOM) group proved optimal, and Heck coupling using Jeffery conditions increased the coupling yield significantly. The results are reported herein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806030      PMCID: PMC5638437          DOI: 10.1021/jo400913k

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  22 in total

1.  Synthesis and biological evaluation of 2- and 7-substituted 9-deazaadenosine analogues.

Authors:  Mao-Chin Liu; Mei-Zhen Luo; Diane E Mozdziesz; Alan C Sartorelli
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2005       Impact factor: 1.381

Review 2.  A review: synthesis of aryl C-glycosides via the heck coupling reaction.

Authors:  Kevin W Wellington; Steven A Benner
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2006       Impact factor: 1.381

3.  pH-Independent triplex formation: hairpin DNA containing isoguanine or 9-deaza-9-propynylguanine in place of protonated cytosine.

Authors:  Frank Seela; Khalil I Shaikh
Journal:  Org Biomol Chem       Date:  2006-10-02       Impact factor: 3.876

4.  Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: convergent synthesis of the aza-C-nucleoside immucillins.

Authors:  G B Evans; R H Furneaux; T L Hutchison; H S Kezar; P E Morris; V L Schramm; P C Tyler
Journal:  J Org Chem       Date:  2001-08-24       Impact factor: 4.354

5.  Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.

Authors:  Orrette R Wauchope; Matthew J Tomney; Joseph L Pepper; Brent E Korba; Katherine L Seley-Radtke
Journal:  Org Lett       Date:  2010-10-15       Impact factor: 6.005

6.  Synthesis of tert-butoxycarbonyl (Boc)-protected purines.

Authors:  S Dey; P Garner
Journal:  J Org Chem       Date:  2000-11-03       Impact factor: 4.354

7.  Synthesis and antitumor activity of thieno-separated tricyclic purines.

Authors:  K L Seley; P Januszczyk; A Hagos; L Zhang; D T Dransfield
Journal:  J Med Chem       Date:  2000-12-14       Impact factor: 7.446

8.  Modular and practical synthesis of 6-substituted pyridin-3-yl C-nucleosides.

Authors:  Nicolas Joubert; Radek Pohl; Blanka Klepetérová; Michal Hocek
Journal:  J Org Chem       Date:  2007-08-01       Impact factor: 4.354

Review 9.  Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.

Authors:  William B Parker
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

10.  Hetero-expanded purine nucleosides. Design, synthesis and preliminary biological activity.

Authors:  Katherine L Seley-Radtke; Zhibo Zhang; Orrette R Wauchope; Sarah C Zimmermann; Alexander Ivanov; Brent Korba
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2008
View more
  2 in total

1.  Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.

Authors:  Kartik W Temburnikar; Sarah C Zimmermann; Nathaniel T Kim; Christina R Ross; Christopher Gelbmann; Christine E Salomon; Gerald M Wilson; Jan Balzarini; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2014-03-03       Impact factor: 3.641

2.  Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.

Authors:  Kartik W Temburnikar; Christina R Ross; Gerald M Wilson; Jan Balzarini; Brian M Cawrse; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2015-06-16       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.